Bioactive glass in tissue engineering

Acta Biomaterialia

Volumn 7, Issue 6, 2011, Pages 2355-2373

  Rahaman, Mohamed N ^a   Day, Delbert E ^a   Sonny Bal, B ^b   Fu, Qiang ^c   Jung, Steven B ^a,d   Bonewald, Lynda F ^e   Tomsia, Antoni P ^c  

^a Architectural and Environmental Engineering   (United States)

^b University of Missouri   (United States)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^d Mo Sci Corporation   (United States)

^e UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF DENTISTRY   (United States)

Author keywords

Angiogenesis; Bioactive glass; Bone repair; Soft tissue repair; Tissue engineering

Indexed keywords

BIOMECHANICS; BONE; DEGRADATION; FRACTURE MECHANICS; REPAIR; SCAFFOLDS (BIOLOGY); SILICATES; TISSUE REGENERATION; TRACE ELEMENTS;

ANGIOGENESIS; BONE FORMATION; BONE REPAIR; GLASSES IN; SCAFFOLD MATERIALS; SOFT TISSUE; SOFT TISSUE REPAIR; TISSUE ENGINEERING APPLICATIONS; TISSUE REPAIR; TISSUES ENGINEERINGS;

BIOACTIVE GLASS;

BIOACTIVE GLASS; BIOCERAMICS; BIOMATERIAL; COPPER; GLASS FIBER; HYDROXYAPATITE; NANOFIBER; SILICATE; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; ANGIOGENESIS; BIODEGRADABLE IMPLANT; BIOLOGICAL ACTIVITY; BONE MINERAL; BONE REGENERATION; BONE REMODELING; CELL ADHESION; CELL INFILTRATION; CELL PROLIFERATION; CELL STIMULATION; CRYSTALLIZATION; DEGRADATION KINETICS; DISSOLUTION; ELECTROSPINNING; ION EXCHANGE; MESENCHYMAL STEM CELL; MICROTECHNOLOGY; NONHUMAN; NUTRIENT UPTAKE; OSSIFICATION; OSTEOMYELITIS; POLYMERIZATION; PRIORITY JOURNAL; REVIEW; SURFACE PROPERTY; TISSUE ENGINEERING; TISSUE GROWTH; TISSUE REPAIR; TRABECULAR BONE; URINARY EXCRETION; VASCULARIZATION; WOUND HEALING;

EID: 79955589951     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2011.03.016     Document Type: Review

References (164)

1. Nerem RM. Cellular engineering. Ann Biomed Eng 1991;19:529-45.
2. Langer R, Vacanti JP. Tissue engineering. Science 1993;260:920-6. (Pubitemid 23209960)
3. Elisseeff J, McIntosh W, Fu K, Blunk R, Langer R. Controlled-release of IGF-I and TGF-β 1 in a photopolymerizing hydrogel for cartilage tissue engineering. J Orthop Res 2001;19:1098-104. (Pubitemid 34000373)
4. Babensee JE, McIntire LV, Mikos AG. Growth factor delivery for tissue engineering. Pharmaceut Res 2000;17:497-504. (Pubitemid 30416385)
5. Shea LD, Smiley E, Bonadio J, Mooney DJ. DNA delivery from polymer matrices for tissue engineering. Nat Biotechnol 1999;17:551-4. (Pubitemid 29262917)
6. Mahoney MJ, Saltzman WM. Transplantation of brain cells assembled around a programmable synthetic microenvironment. Nat Biotechnol 2001;19:934-9. (Pubitemid 32947571)
7. Cooper ML, Hansbrough JF. Use of a composite skin graft composed of cultured human keratinocytes and fibroblasts and a collagen-GAG matrix to cover full-thickness on athymic mice. Surgery 1991;109:198-207.
8. Hansbrough JF, Morgan J, Greenleaf G, Parikh M, Nolte C, Wilkins L. Evaluation of Graftskin* composite grafts on full-thickness wounds on athymic mice. J Burn Care Rehabil 1994;15:346-53. (Pubitemid 24233507)
9. Eaglstein WH, Falanga V. Tissue engineering and the development of Apligraf®, a human skin equivalent. Clin Ther 1997;19:894-905. (Pubitemid 27508925)
10. Black AF, Berthod F, L'Heureux N, Germain L, Auger FA. In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent. FASEB J 1998;12:1331-40.
11. Vacanti CA, Bonassar LJ, Vacanti MP, Shufflebarger J. Replacement of an avulsed phalanx with tissue-engineered bone. N Eng J Med 2001;344: 1511-4. (Pubitemid 32429210)
12. Kruyt MC, van Gaalen SM, Oner FC, Verbout AJ, deBruijn JD, Dhert WJA. Bone tissue engineering and spinal fusion: the potential of hybrid constructs by combining osteoprogenitor cells and scaffolds. Biomaterials 2004;25:1463-73.
13. Marcacci M, Kon E, Moukhachev V, Lavroukov A, Kutepov S, Quarto R, et al. Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Eng 2007;13:947-55. (Pubitemid 46870419)
14. Cao Y, Vacanti JP, Paige KT, Upton J, Vacanti CA. Transplantation of chondrocytes utilizing a polymer-cell construct to produce tissue-engineered cartilage in the shape of a human ear. Plastic Reconstr Surg 1997;100:297-302.
15. Valonen PK, Moutos FT, Kusanagi A, Moretti MG, Diekman BO, Welter JF, et al. In vitro generation of mechanically functional cartilage grafts based on adult human stem cells and 3-D-woven poly(e-caprolactone) scaffolds. Biomaterials 2010;31:2193-200.
16. Rahaman MN, Mao JJ. Stem cell-based composite tissue constructs for regenerative medicine. Biotechnol Bioeng 2005;91:261-84. (Pubitemid 41076840)
17. Hutmacher DW. Scaffold design and fabrication technologies for engineering tissues - state of the art and future perspectives. J Biomater Sci: Polym Ed 2001;12:107-24. (Pubitemid 32335467)
18. Griffith LG. Emerging design principles in biomaterials and scaffolds for tissue engineering. Ann NY Acad Sci 2002;961:83-95. (Pubitemid 34721746)
19. Li WJ, Laurencin CT, Caterson EJ, Tuan RS, Ko FK. Electrospun nanofibrous structure: a novel scaffold for tissue engineering. J Biomed Mater Res 2002;60:613-21. (Pubitemid 34492600)
20. Shin M, Yoshimoto H, Vacanti JP. In vivo bone tissue engineering using mesenchymal stem cells on a novel electrospun nanofibrous scaffold. Tissue eng 2004;10:33-41.
21. Hollister SJ. Porous scaffold design for tissue engineering. Nat Mater 2005;4:518-24. (Pubitemid 40952745)
22. Deville S, Saiz E, Tomsia A. Freeze casting of hydroxyapatite scaffolds for bone tissue engineering. Biomaterials 2006;27:5480-9. (Pubitemid 44176143)
23. Griffith LG. Polymeric biomaterials. Acta Mater 2000;48:263-77. (Pubitemid 30558407)
24. Agrawal CM, Ray RB. Biodegradable polymer scaffolds for musculoskeletal tissue engineering. J Biomed Mater Res 2001;55:141-50. (Pubitemid 32198496)
25. Hayashi T. Biodegradable polymers for biomedical uses. Prog Polym Sci 1994;19:663-702. (Pubitemid 124003804)
26. Reis RL, editor. Natural-based polymers for biomedical applications. Cambridge: Woodhead Publishing; 2008.
27. Lee KY, Mooney DJ. Hydrogels for tissue engineering. Chem Rev 2001;101:1869-78.
28. Varghese S, Elisseeff JH. Hydrogels for musculoskeletal tissue engineering. Adv Polym Sci 2006;203:95-144.
29. Thompson RC, Yaszemski MJ, Powers JM, Mikos AG. Hydroxyapatite fiber-reinforced poly(-hydroxy ester) foams for bone regeneration. Biomaterials 1998;19:1935-43. (Pubitemid 28528795)
30. Zhang R, Ma PX. Poly(α-hydroxyl acids)/hydroxyapatite porous composites for bone tissue engineering. I. Preparation and morphology. J Biomed Mater Res 1999;44:446-55. (Pubitemid 29031128)
31. Lu HH, El-Amin SF, Scott KD, Laurencin CT. Three-dimensional, bioactive, biodegradable, polymer-bioactive glass composite scaffolds with improved mechanical properties support collagen synthesis and mineralization of human osteoblast-like cells in vitro. J Biomed Mater Res 2003;64A: 465-74. (Pubitemid 37522486)
32. Kim S-S, Ahn KM, Park MS, Lee J-H, Choi CY, Kim B-S. A poly(lactide coglycolide)/ hydroxyapatite composite scaffold with enhanced osteoconductivity. J Biomed Mater Res 2007;80A:206-15. (Pubitemid 44913348)
33. Witte F, Kaese V, Haferkamp H, Switzer E, Meyer-Lindenberg A, Wirth CJ, et al. In vivo corrosion of four magnesium alloys and the associated bone response. Biomaterials 2005;26:3557-63.
34. LeGeros RZ, LeGeros JP. Phosphate minerals in human tissues. In: Nriagu JO, Moore PB, editors. Phosphate minerals. Berlin: Springer-Verlag; 1984. p. 351-85.
35. Hench LL, Wilson J, editors. An introduction to bioceramics. Singapore: World Scientific; 1993.
36. Gauthier O, Goyenvalle E, Bouler J, Guicheux J, Pilet P, Weiss P, et al. Macroporous biphasic calcium phosphate ceramics versus injectable bone substitute: a comparative study 3 and 8 weeks after implantation in rabbit bone. J Mater Sci Mater Med 2001;12:385-90. (Pubitemid 32488113)
37. Bandyopadhyay A, Bernard S, Xue W, Bose S. Calcium phosphate-based resorbable ceramics: influence of MgO, ZnO, and SiO2 dopants. J Am Ceram Soc 2006;89:2675-88. (Pubitemid 44266407)
38. Klein C, Patka P, den Hollander W. Macroporous calcium phosphate bioceramics in dog femora: a histological study of interface and biodegradation. Biomaterials 1989;10:59-62. (Pubitemid 19052591)
39. Martin RB, Chapman MW, Sharkey NA, Zissimos SL, Bay B, Shors EC. Bone ingrowth and mechanical properties of coralline hydroxyapatite 1 year after implantation. Biomaterials 1993;14:341-8.
40. Daculsi G, Laboux O, Malard O, Weiss P. Current state of the art of biphasic calcium phosphate bioceramics. J Mater Sci Mater Med 2003;14:195-200. (Pubitemid 36408018)
41. Wagoner Johnson AJ, Herschler BA. A review of the mechanical behavior of CaP and CaP/polymer composites for applications in bone replacement and repair. Acta Biomater 2011;7:16-30.
42. Hench LL, Wilson J. Surface active biomaterials. Science 1984;226:630-6.
43. Yamamuro T, Hench LL, Wilson J, editors. Handbook of bioactive ceramics, vols. 1 and 2. Boca Raton, FL: CRC Press; 1990.
44. Hench LL. Bioceramics. J Am Ceram Soc 1998;81:1705-28.
45. Rahaman MN, Brown RF, Bal BS, Day DE. Bioactive glasses for non-bearing applications in total joint replacement. Semin Arthroplasty 2007;17:102-12.
46. Williams DF, editor. Definitions in biomaterials. New York: Elsevier; 1987.
47. Kokubo T, Takadama H. How useful is SBF in predicting in vivo bone bioactivity? Biomaterials 2006;27:2907-15.
48. Kokubo T, Kushitani H, Sakka S, Kitsugi T, Yamamuro T. Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W. J Biomed Mater Res 1990;24:721-34. (Pubitemid 20236523)
49. Ducheyne P. Bioceramics: materials characteristics versus in vivo behavior. J Biomed Mater Res 1987;21(A2 Suppl.):219-36.
50. Bohner M, Lemaître J. Can bioactivity be tested in vitro with SBF solution? Biomaterials 2009;30:2175-9.
51. Ohura K, Bohner M, Hardouin P, Lemaître J, Pasquier G, Flautre B. Resorption of, and bone formation from, new b-tricalcium phosphate-monocalcium phosphate cements: an in vivo study. J Biomed Mater Res 1996;30:1993-2000.
52. Apelt D, Theiss F, El-Warrak AO, Zlinszky K, Bettschart-Wolfisberger R, Bohner M, et al. In vivo behavior of three different injectable hydraulic calcium phosphate cements. Biomaterials 2004;25:1439-51.
53. Theiss F, Apelt D, Brand B, Kutter A, Zlinszky K, Bohner M, et al. Biocompatibility and resorption of a brushite calcium phosphate cement. Biomaterials 2005;26:4383-94. (Pubitemid 40208599)
54. Kotani S, Fujita Y, Kitsugi T, Nakamura T, Yamamuro T, Ohtsuki C, et al. Bone bonding mechanisms of β -tricalcium phosphate. J Biomed Mater Res 1991;25:1303-15.
55. Hench LL, Splinter RJ, Allen WC, Greenlee Jr TK. Bonding mechanisms at the interface of ceramic prosthetic materials. J Biomed Mater Res 1971;5:117-41.
56. Huang W, Day DE, Kittiratanapiboon K, Rahaman MN. Kinetics and mechanisms of the conversion of silicate (45S5), borate, and borosilicate glasses to hydroxyapatite in dilute phosphate solution. J Mater Sci Mater Med 2006;17:583-96. (Pubitemid 43886421)
57. Huang W, Rahaman MN, Day DE, Li Y. Mechanisms of converting silicate, borate, and borosilicate glasses to hydroxyapatite in dilute phosphate solution. Phys Chem Glasses Europ J Glass Sci Technol B 2006;47:647-58.
58. Rohanová D, Boccaccini AR, Yunos DM, Horhavková D, Březovska I, Helebrant A. TRIS buffer in simulated body fluid (SBF) distorts the assessment of glassceramic scaffold bioactivity. Acta Biomater, 2011;7:2623-2630.
59. Hench LL, Polak JM. Third-generation biomaterials. Science 2002;295:1014-7.
60. Ducheyne P, Qiu Q. Bioactive ceramics: the effect of surface reactivity on bone formation and bone cell function. Biomaterials 1999;20:2287-303.
61. Wilson J, Pigott GH, Schoen FJ, Hench LL. Toxicology and biocompatibility of bioglasses. J Biomed Mater Res 1981;15:805-17. (Pubitemid 12239956)
62. Lai W, Garino J, Ducheyne P. Silicon excretion from bioactive glass implanted in rabbit bone. Biomaterials 2002;23:213-7. (Pubitemid 33041356)
63. Chen ZQ, Thompson ID, Boccaccini AR. 45S5 Bioglass®-derived glass-ceramic scaffold for bone tissue engineering. Biomaterials 2006;27:2414-25. (Pubitemid 41821820)
64. Filho OP, LaTorr GP, Hench LL. Effect of crystallization on apatite-layer formation on bioactive glass 45S5. J Biomed Mater Res 1996;30:509-14. (Pubitemid 26107084)
65. Yao A, Wang DP, Huang W, Rahaman MN, Day DE. In vitro bioactive characteristics of borate-based glasses with controllable degradation behavior. J Am Ceram Soc 2007;90:303-6.
66. Fu Q, Rahaman MN, Fu H, Liu X. Bioactive glass scaffolds with controllable degradation rates for bone tissue engineering applications. I. Preparation and in vitro degradation. J Biomed Mater Res 2010;95A:164-71.
67. Brink M. The influence of alkali and alkali earths on the working range for bioactive glasses. J Biomed Mater Res 1997;36:109-17. (Pubitemid 27271004)
68. 2. J Biomed Mater Res 1997;37:114-21.
69. Brown RF, Day DE, Day TE, Jung S, Rahaman MN, Fu Q. Growth and differentiation of osteoblastic cells on 13-93 bioactive glass fibers and scaffolds. Acta Biomater 2008;4:387-96. (Pubitemid 351218086)
70. Day DE, White JE, Brown RF, McMenamin KD. Transformation of borate glasses into biologically useful materials. Glass Technol Part A 2003;44:75-81.
71. Day DE, Erbe EM, Richard M, Wojcik JA. Bioactive materials. US Patent No. 6709,744 [March 23, 2004].
72. Han X, Day DE. Reaction of sodium calcium borate glasses to form hydroxyapatite. J Mater Sci Mater Med 2007;18:1837-47. (Pubitemid 47224917)
73. 3-containing borate glass to hydroxyapatite in aqueous phosphate solution. Acta Biomater 2009;5:1265-73.
74. Pan H, Zhao X, Zhang X, Zhang K, Li L, Li Z, et al. Strontium borate glass: potential biomaterial for bone regeneration. J Roy Soc Interface 2010;7:1025-31.
75. Marion N, Liang W, Reilly G, Day DE, Rahaman MN, Mao JJ. Bioactive borate glass supports the osteogenic potential of human mesenchymal stem cells. Mech Adv Mater Struct 2005;12:239-46. (Pubitemid 41673169)
76. Fu H, Fu Q, Zhou N, Huang W, Rahaman MN, Wang D, et al. In vitro evaluation of borate-based bioactive glass scaffolds prepared by a polymer foam replication method. Mater Sci Eng C 2009;29:2275-81.
77. Fu Q, Rahaman MN, Bal BS, Bonewald LF, Kuroki K, Brown RF. Bioactive glass scaffolds with controllable degradation rates for bone tissue engineering applications. II. In vitro and in vivo biological evaluation. J Biomed Mater Res 2010;95A:172-9.
78. Liu X, Xie Z, Zhang C, Pan H, Rahaman MN, Zhang X, et al. Bioactive borate glass scaffolds: in vitro and in vivo evaluation for use as a drug delivery system in the treatment of bone infection. J Mater Sci Mater Med 2010;21:575-82.
79. Jia WT, Zhang X, Luo SH, Huang WH, Rahaman MN, Day DE, et al. Novel borate glass/chitosan composite as a delivery vehicle for teicoplanin in the treatment of chronic osteomyelitis. Acta Biomater 2010;6:812-9.
80. Zhang X, Jia W, Gu Y, Liu X, Wang D, Zhang C, et al. Teicoplanin-loaded borate bioactive glass implants for treating chronic bone infection in a rabbit tibia osteomyelitis model. Biomaterials 2010;31:5865-74.
81. Brown RF, Rahaman MN, Dwilewicz AB, Huang W, Day DE, Li Y, et al. Conversion of borate glass to hydroxyapatite and its effect on proliferation of MC3T3-E1 cells. J Biomed Mater Res 2009;88A:392-400.
82. Jung SB, Day DE, Brown RF, Bonewald LF. Potential toxicity of bioactive borate glasses in vitro and in vivo, submitted for publication.
83. 5 glasses. Biomaterials 1998;19:2277-84.
84. Franks K, Abrahams I, Knowles JC. Development of soluble glasses for biomedical use. Part I. In vitro solubility measurement. J Mater Sci Mater Med 2000;11:609-14.
85. Salih V, Franks K, James M, Hastings GW, Knowles JC, Olsen I. Development of soluble glasses for biomedical use. Part II. The biological response of human osteoblast cell lines to phosphate-based soluble glasses. J Mater Sci Mater Med 2000;11:615-20.
86. 2O glass system. Biomaterials 2004;25:491-9.
87. 2O glass fiber system. Biomaterials 2004;25:501-7.
88. Wheeler DL, Stokes KE, Park HM, Hollinger JO. Evaluation of particulate Bioglass® in a rabbit radius ostectomy model. J Biomed Mater Res 1997;35:249-54. (Pubitemid 27188289)
89. Wheeler DL, Stokes KE, Hoellrich RG, Chamberlain DL, McLoughlin SW. Effect of bioactive glass particle size on osseous regeneration of cancellous defects. J Biomed Mater Res 1998;41:527-33. (Pubitemid 28355436)
90. Oonishi H, Hench LL, Wilson J, Sugihara F, Tsuji E, Kushitani S, et al. Comparative bone growth behavior in granules of bioceramic materials of various sizes. J Biomed Mater Res 1999;44:31-43. (Pubitemid 28544083)
91. Xynos ID, Hukkanen MVJ, Batten JJ, Buttery LD, Hench LL, Polak JM. Bioglass® 45S5 stimulates osteoblast turnover and enhances bone formation in vitro: implications and applications for bone tissue engineering. Calcif Tissue Int 2000;67:321-9.
92. Xynos ID, Edgar AJ, Buttery LDK, Hench LL, Polak JM. Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophys Res Comm 2000;276:461-5.
93. Xynos ID, Edgar AJ, Buttery LDK, Hench LL, Polak JM. Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass® 45S5 dissolution. J Biomed Mater Res 2001;55:151-7. (Pubitemid 32198497)
94. Bohner M. Silicon-substituted calcium phosphates - a critical review. Biomaterials 2009;30:6403-6.
95. Bi L, Jung SB, Day DE, Neidig K, Dusevich V, Eick D, et al. Evaluation of bone regeneration, angiogenesis, and hydroxyapatite conversion in critical-sized rat calvarial defects implanted with bioactive glass scaffolds, in preparation.
96. Hulbert SF, Young FA, Mathews RS, Klawitter JJ, Talbert CD, Stelling FH. Potential of ceramic materials as permanently implantable skeletal prostheses. J Biomed Mater Res 1970;4:433-56.
97. Hollinger JO, Brekke J, Gruskin E, Lee D. Role of bone substitutes. Clin Orthop Relat Res 1996;324:55-65. (Pubitemid 26071751)
98. Pirhonen E, Moimas L, Haapanen J. Porous bioactive 3-D glass fiber scaffolds for tissue engineering applications manufactured by sintering technique. Key Eng Mater 2003;240-242:237-40.
99. Fu Q, Rahaman MN, Bal BS, Huang W, Day DE. Preparation and bioactive characteristics of a porous 13-93 glass, and fabrication into the articulating surface of a proximal tibia. J Biomed Mater Res 2007;82A: 222-9. (Pubitemid 46906509)
100. Liang W, Rahaman MN, Day DE, Marion NW, Riley GC, Mao JJ. Bioactive borate glass scaffold for bone tissue engineering. J. Non-Crystalline Solids 2008;354:1690-6.
101. Jung SB, Day DE, Brown RF. Angiogenic bioactive borate glasses, submitted for publication.
102. Fu Q, Rahaman MN, Bal BS, Brown RF, Day DE. Mechanical and in vitro performance of 13-93 bioactive glass scaffolds prepared by a polymer foam replication technique. Acta Biomater 2008;4:1854-64.
103. Liu X, Pan H, Fu H, Fu Q, Rahaman MN, Huang W. Conversion of borate-based glass scaffold to hydroxyapatite in dilute phosphate solution. Biomed Mater 2010;5:015005.
104. Wang HW, Tabata Y, Ikada Y. Fabrication of porous gelatin scaffolds for tissue engineering. Biomaterials 1999;20:1339-44. (Pubitemid 29281386)
105. Fukasawa T, Ando M, Ohji T, Kanzaki S. Synthesis of porous ceramics with complex pore structure by freeze-dry processing. J Am Ceram Soc 2001;84:230-2. (Pubitemid 33642642)
106. Schoof H, Apel J, Heschel I, Rau G. Control of pore structure and size in freeze-dried collagen sponges. J Biomed Mater Res Appl Biomater 2001;58:352-7. (Pubitemid 32643182)
107. Zhang H, Hussain I, Brust M, Butler MF, Rannard S, Cooper AI. Aligned twoand three-dimensional structures by directional freezing of polymers and nanoparticles. Nat Mater 2005;4:787-93. (Pubitemid 41397029)
108. Fu Q, Rahaman MN, Dogan F, Bal BS. Freeze casting of porous hydroxyapatite scaffolds. I. Processing and general microstructure. J Biomed Mater Res 2008;86B:125-35.
109. Fu Q, Rahaman MN, Dogan F, Bal BS. Freeze casting of porous hydroxyapatite scaffolds. II. Sintering, microstructure, and mechanical behavior. J Biomed Mater Res 2008;86B:514-22.
110. Fu Q, Rahaman MN, Bal BS, Brown RF. Preparation and in vitro evaluation of bioactive glass (13-93) scaffolds with oriented microstructures for repair and regeneration of load-bearing bones. J Biomed Mater Res 2010;93A: 1380-90.
111. Liu X, Rahaman MN, Fu Q. Oriented bioactive glass (13-93) scaffolds with controllable pore size by unidirectional freezing of camphene-based suspensions: microstructure and mechanical response. Acta Biomater 2011;7:410-6.
112. Fu Q, Rahaman MN, Bal BS, Kuroki K, Brown RF. In vivo evaluation of 13-93 bioactive glass scaffolds with trabecular and oriented microstructures in a rat subcutaneous implantation model. J Biomed Mater Res 2010;95A:235-44.
113. Pham DT, Dimov SS, editors. The technologies and applications of rapid prototyping and rapid tooling. London: Springer; 2000.
114. Sachlos E, Czernuszka JT. Making tissue engineering scaffolds work. Review of the application of solid freeform fabrication technology to the production of tissue engineering scaffolds. Eur Cells Mater 2003;5:29-40.
115. Chu TMG. Solid freeform fabrication of tissue engineering scaffolds. In: Ma PX, Elisseeff JH, editors. Scaffolding in tissue engineering. Boca Raton, FL: Taylor & Francis; 2005. p. 139-54.
116. Rezwan K, Chen QZ, Blaker JJ, Boccaccini AR. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 2006;27:3413-31.
117. Russias J, Saiz E, Deville S, Tomsia AP. Fabrication and in-vitro characterization of three-dimensional composite scaffolds by robocasting for biomedical applications. Adv Sci Technol 2006;49:153-8.
118. Fu Q, Saiz E, Tomsia AP. Bio-inspired highly porous and strong glass scaffolds. Adv Funct Mater 2011;21:1058-63.
119. Huang TS, Rahaman MN, Doiphode ND, Leu MC, Bal BS, Day DE. Porous and strong bioactive glass (13-93) scaffolds prepared by freeze extrusion fabrication. Mater Sci Eng C, submitted for publication.
120. Velez M. Selective laser sintering of bioglass for bone tissue engineering. SBIR/STTR Phase I Final Report. Rolla, MO: Corp.; 2010.
121. Sepulveda P, Jones JR, Hench LL. Bioactive sol-gel foams for tissue repair. J Biomed Mater Res 2002;59:340-8.
122. Jones JR, Poologasundarampillai G, Atwood RC, Bernard D, Lee PD. Nondestructive quantitative 3-D analysis for the optimization of tissue scaffolds. Biomaterials 2007;28:1404-13. (Pubitemid 44959043)
123. Jones JR, Ehrenfried LM, Hench LL. Optimizing bioactive glass scaffolds for bone tissue engineering. Biomaterials 2006;27:964-73. (Pubitemid 41566688)
124. Kim H-W, Kim H-E, Knowles JC. Production and potential of bioactive glass nanofibers as a next-generation biomaterial. Adv Func Mater 2006;16:1529-35. (Pubitemid 44266040)
125. Lu H, Zhang T, Wang XP, Fang QF. Electrospun submicron bioactive glass fibers for bone tissue scaffold. J Mater Sci Mater Med 2009;20:793-8.
126. Jung SB, Day DE. Conversion kinetics of silicate, borosilicate, and borate bioactive glasses to hydroxyapatite. Phys Chem Glasses Eur J Glass Sci Technol B 2009;50:85-8.
127. Rahaman MN, Day DE, Brown RF, Fu Q, Jung SB. Nanostructured bioactive glass scaffolds for bone repair. Cer Eng Sci Proc 2008;29:211-25.
128. Conzone SD, Day DE. Preparation and properties of porous microspheres made form borate glass. J Biomed Mater Res 2009;88A:531-42.
129. Wang Q, Huang W, Wang D, Darvell BW, Day DE, Rahaman MN. Preparation of hollow hydroxyapatite microspheres. J Mater Sci Mater Med 2006;17:641-6. (Pubitemid 43886428)
130. Huang W, Rahaman MN, Day DE, Miller BA. Strength of hollow hydroxyapatite microspheres prepared by a glass conversion process. J Mater Sci Mater Med 2009;20:123-9.
131. Fu H, Rahaman MN, Day DE, Fu Q. Effect of process parameters on the microstructure of hollow hydroxyapatite microspheres prepared by a glass conversion method. J Am Ceram Soc 2010;93:3116-23.
132. Martin RB, Burr DB, Sharkey NA. Skeletal tissue mechanics. New York: Springer-Verlag; 1998.
133. Goldstein SA. The mechanical properties of trabecular bone: dependence on anatomic location and function. J Biomech 1987;20:1055-62.
134. Reilly DT, Burstein AH, Frankel VH. The elastic modulus of bone. J Biomech 1974;7:271-5.
135. Fung YC. Biomechanics: mechanical properties of living tissues. New York: Springer; 1993.
136. Rho JY, Hobatho MC, Ashman RB. Relations of density and CT numbers to mechanical properties for human cortical and cancellous bone. Med Eng Phys 1995;17:347-55.
137. Ma PX, Zhang R. Microtubular architecture of biodegradable polymer scaffolds. J Biomed Mater Res 2001;56:469-77. (Pubitemid 32606007)
138. Stokols S, Tuszynski MH. Freeze-dried agarose scaffolds with uniaxial channels stimulate and guide linear axonal growth following spinal cord injury. Biomaterials 2006;27:443-51. (Pubitemid 41457247)
139. Kim Y, Haftel VK, Kumar S, Bellamkonda RV. The role of aligned polymer fiber-based constructs in the bridging of long peripheral nerve gaps. Biomaterials 2008;29:3117-27.
140. Heindel JJ, Price CJ, Schwetz BA. The developmental toxicity of boric acid in mice, rats, and rabbits. Environ Health Perspect 1994;102:107-12.
141. Fu Q, Huang W, Jia W, Rahaman MN, Liu X, Tomsia AP. Osteoconduction and osteointegration by bioactive borate glass in a rabbit tibia model: a synchrotron X-ray micro computerized tomography (SR microCT) study. Tissue Eng Part A, submitted for publication.
142. Carmeliet P. Manipulating angiogenesis in medicine. J Intern Med 2004;255:538-61. (Pubitemid 38534868)
143. Gorustovich AA, Perio C, Roether JA, Boccaccini AR. Effect of bioactive glasses on angiogenesis: a review of in vitro and in vivo evidence. Tissue Eng B 2010;16:199-207.
144. Day RM, Boccaccini AR, Shurey S, Roether JA, Forbes A, Hench LL, et al. Assessment of poly(glycolic acid) mesh and bioactive glass for soft tissue engineering scaffolds. Biomaterials 2004;25:5857-66.
145. Keshaw H, Forbes A, Day RM. Release of angiogenic growth factors from cells encapsulated in alginate beads with bioactive glass. Biomaterials 2005;26:4171-9. (Pubitemid 40138663)
146. Day RM. Bioactive glass stimulates the secretion of angiogenic growth factors and angiogenesis in vitro. Tissue Eng 2005;11:768-77. (Pubitemid 40960780)
147. Leach JK, Kaigler D, Wang Z, Kresbach PH, Mooney DJ. Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration. Biomaterials 2006;27:3249-55. (Pubitemid 43344337)
148. Leu A, Leach JK. Proangiogenic potential of a collagen bioactive glass substrate. Pharmaceut Res 2008;25:1122-9.
149. Leu A, Stieger SM, Dayton P, Ferrara KW, Leach JK. Angiogenic response to bioactive glass promotes bone healing in an irradiated calvarial defect. Tissue Eng Part A 2008;15:877-85.
150. McAuslan BR, Reilly W. Endothelial cell phagokinesis in response to specific metal ions. Exp Cell Res 1980;130:147-57. (Pubitemid 11189744)
151. Raju KS, Alessandri G, Ziche M, Gullino PM. Ceruloplasmin, copper ions, and angiogenesis. J Natl Cancer Inst 1982;69:1183-8. (Pubitemid 13254912)
152. Hu GF. Copper stimulates proliferation of human endothelial cells under culture. J Cell Biochem 1998;69:326-35.
153. Sen CK, Khanna S, Venojarvi M, Trikha P, Ellison EC, Hunt TK, et al. Copper-induced vascular endothelial growth factor expression and wound healing. Am J Physiol Heart Circ Physiol 2002;282:H1821-7.
154. Frangoulis M, Georgiou P, Chrisostomidis C, Perrea D, Dontas I, Kavantzas N, et al. Rat epigastric flap survival and VEGF expression after local copper application. Plast Reconstr Surg 2007;119:837-43.
155. Tan AR, Barsi JM, Jayabalan PS, Rahaman MN, Bal BS, Ateshian GA, et al. Bioactive glass as a medium supplement for culturing tissue-engineered cartilage. Transactions of the 55th Annual Meeting of the Orthopaedic Research Society, vol. 34. Las Vegas, NV; 2009. p. 1314.
156. Jayabalan PS, Tan AR, Rahaman MN, Bal BS, Hung CT, Cook JL. Bioactive glass (13-93) as a subchondral substrate for tissue-engineered osteochondral constructs. Clin Orthop Rel Res, in press.
157. Lima EG, Bian L, Ng KW, Mauck RL, Byers BA, Tuan RS, et al. The beneficial effect of delayed compressive loading on tissue-engineered cartilage constructs cultured with TGF-β 3. Osteoarthritis Cartilage 2007;15:1025-33.
158. Lima EG, Tan AR, Tai T, Bian L, Stoker AM, Ateshian GA, et al. Differences in interleukin-1 response between engineered and native cartilage. Tissue Eng Part A 2008;14:1721-30.
159. Kelly TA, Ng KW, Wang CC, Ateshian GA, Hung CT. Spatial and temporal development of chondrocytes-seeded agarose constructs in free-swelling and dynamically loaded cultures. J Biomech 2006;39:1489-97. (Pubitemid 44262072)
160. Hunziker EB. The elusive path to cartilage regeneration. Adv Mater 2009;21:3419-24.
161. Hunziker EB. Articular cartilage repair: basic science and clinical progress. A review of current status and prospects. Osteoarthritis Cartilage 2001;10:432-63.
162. Freed LE, Engelmayr Jr GC, Borenstein JT, Moutos FT, Guilak F. Advanced material strategies for tissue engineering scaffolds. Adv Mater 2009;21:3410-8.
163. Bal BS, Rahaman MN, Jayabalan PS, Kuroki K, Cockrell Mary K, Yao JQ, et al. In vivo outcomes of tissue-engineered osteochondral grafts. J Biomed Mater Res 2010;93B:164-74.
164. Liu X, Rahaman MN, Fu Q. Effect of cooling rate on pore orientation and mechanical strength of 13-93 bioactive glass scaffolds prepared by unidirectional freezing of camphene-based suspensions. Acta Biomater, submitted for publication.